Marovich M, Mascola JR, Cohen MS. Monoclonal antibodies for prevention and treatment of COVID-19. JAMA. 2020;324(2):131–2.

Article  CAS  PubMed  Google Scholar 

Gaudinski MR, Berkowitz NM, Idris AH, Coates EE, Holman LA, Mendoza F, Gordon IJ, Plummer SH, Trofymenko O, Hu Z, et al. A monoclonal antibody for Malaria Prevention. N Engl J Med. 2021;385(9):803–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Low JG, Ng JHJ, Ong EZ, Kalimuddin S, Wijaya L, Chan YFZ, Ng DHL, Tan HC, Baglody A, Chionh YH, et al. Phase 1 trial of a therapeutic Anti-yellow fever virus human antibody. N Engl J Med. 2020;383(5):452–9.

Article  CAS  PubMed  Google Scholar 

Taylor PC, Adams AC, Hufford MM, de la Torre I, Winthrop K, Gottlieb RL. Neutralizing monoclonal antibodies for treatment of COVID-19. Nat Rev Immunol. 2021;21(6):382–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wieten RW, Goorhuis A, Jonker EFF, de Bree GJ, de Visser AW, van Genderen PJJ, Remmerswaal EBM, Ten Berge IJM, Visser LG, Grobusch MP, et al. 17D Yellow Fever vaccine elicits comparable long-term immune responses in healthy individuals and immune-compromised patients. J Infect. 2016;72(6):713–22.

Article  CAS  PubMed  Google Scholar 

Wieten RW, Jonker EF, Pieren DK, Hodiamont CJ, van Thiel PP, van Gorp EC, de Visser AW, Grobusch MP, Visser LG, Goorhuis A. Comparison of the PRNT and an immune fluorescence assay in Yellow Fever vaccinees receiving immunosuppressive medication. Vaccine. 2016;34(10):1247–51.

Article  CAS  PubMed  Google Scholar 

Gao Y, Zhao Y, Guyatt G, Fowler R, Kojan R, Ge L, Tian J, Collaborators, Hao Q. Effects of therapies for Ebola virus Disease: a systematic review and network meta-analysis. Lancet Microbe. 2022;3(9):e683-692.

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Melo GD, Sonthonnax F, Lepousez G, Jouvion G, Minola A, Zatta F, Larrous F, Kergoat L, Mazo C, Moigneu C, et al. A combination of two human monoclonal antibodies cures symptomatic rabies. EMBO Mol Med. 2020;12(11): e12628.

Article  PubMed  PubMed Central  Google Scholar 

World Health O. Rabies vaccines: WHO position paper, April 2018 - recommendations. Vaccine. 2018;36(37):5500–3.

Article  Google Scholar 

van Griensven J, Edwards T, de Lamballerie X, Semple MG, Gallian P, Baize S, Horby PW, Raoul H, Magassouba N, Antierens A, et al. Evaluation of convalescent plasma for Ebola Virus Disease in Guinea. N Engl J Med. 2016;374(1):33–42.

Article  PubMed  PubMed Central  Google Scholar 

Jackson AC, Warrell MJ, Rupprecht CE, Ertl HC, Dietzschold B, O’Reilly M, Leach RP, Fu ZF, Wunner WH, Bleck TP, et al. Management of rabies in humans. Clin Infect Dis. 2003;36(1):60–3.

Article  PubMed  Google Scholar 

Pantaleo G, Correia B, Fenwick C, Joo VS, Perez L. Antibodies to combat viral Infections: development strategies and progress. Nat Rev Drug Discov. 2022;21(9):676–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bournazos S, Corti D, Virgin HW, Ravetch JV. Fc-optimized antibodies elicit CD8 immunity to viral Respiratory Infection. Nature. 2020;588(7838):485–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256(5517):495–7.

Article  CAS  PubMed  Google Scholar 

Hansel TT, Kropshofer H, Singer T, Mitchell JA, George AJ. The safety and side effects of monoclonal antibodies. Nat Rev Drug Discov. 2010;9(4):325–38.

Article  CAS  PubMed  Google Scholar 

Subramanian KN, Weisman LE, Rhodes T, Ariagno R, Sanchez PJ, Steichen J, Givner LB, Jennings TL, Top FH Jr, Carlin D, et al. Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. MEDI-493 Study Group. Pediatr Infect Dis J. 1998;17(2):110–5.

Article  CAS  PubMed  Google Scholar 

Lee WS, Wheatley AK, Kent SJ, DeKosky BJ. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies. Nat Microbiol. 2020;5(10):1185–91.

Article  CAS  PubMed  Google Scholar 

Pecetta S, Finco O, Seubert A. Quantum Leap of monoclonal antibody (mAb) discovery and development in the COVID-19 era. Semin Immunol. 2020;50: 101427.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park M, Tan KB, Vasoo S, Dickens BL, Lye D, Cook AR. Estimated health outcomes and costs associated with use of monoclonal antibodies for prevention or mitigation of SARS-CoV-2 Infections. JAMA Netw Open. 2022;5(4):e225750.

Article  PubMed  PubMed Central  Google Scholar 

Moekotte AL, Huson MA, van der Ende AJ, Agnandji ST, Huizenga E, Goorhuis A, Grobusch MP. Monoclonal antibodies for the treatment of Ebola virus Disease. Expert Opin Investig Drugs. 2016;25(11):1325–35.

Article  CAS  PubMed  Google Scholar 

Gonzalez-Gonzalez E, Alvarez MM, Marquez-Ipina AR, Trujillo-de Santiago G, Rodriguez-Martinez LM, Annabi N, Khademhosseini A. Anti-ebola therapies based on monoclonal antibodies: current state and challenges ahead. Crit Rev Biotechnol. 2017;37(1):53–68.

Article  CAS  PubMed  Google Scholar 

Grobusch MP, Weld L, Goorhuis A, Hamer DH, Schunk M, Jordan S, Mockenhaupt FP, Chappuis F, Asgeirsson H, Caumes E, et al. Travel-related Infections presenting in Europe: a 20-year analysis of EuroTravNet surveillance data. Lancet Reg Health Eur. 2021;1: 100001.

Article  PubMed  Google Scholar 

Castro MC, Wilson ME, Bloom DE. Disease and economic burdens of dengue. Lancet Infect Dis. 2017;17(3):e70-78.

Article  PubMed  Google Scholar 

Sridhar S, Luedtke A, Langevin E, Zhu M, Bonaparte M, Machabert T, Savarino S, Zambrano B, Moureau A, Khromava A, et al. Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy. N Engl J Med. 2018;379(4):327–40.

Article  PubMed  Google Scholar 

Wong JM, Adams LE, Durbin AP, Munoz-Jordan JL, Poehling KA, Sanchez-Gonzalez LM, Volkman HR, Paz-Bailey G. Dengue: a growing Problem with New interventions. Pediatrics. 2022;149(6):e2021055522.

Article  PubMed  Google Scholar 

Biswal S, Borja-Tabora C, Martinez Vargas L, Velasquez H, Theresa Alera M, Sierra V, Johana Rodriguez-Arenales E, Yu D, Wickramasinghe VP, Duarte Moreira EJ, et al. Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial. Lancet. 2020;395(10234):1423–33.

Article  CAS  PubMed  Google Scholar 

Modhiran N, Song H, Liu L, Bletchly C, Brillault L, Amarilla AA, Xu X, Qi J, Chai Y, Cheung STM, et al. A broadly protective antibody that targets the flavivirus NS1 protein. Science. 2021;371(6525):190–4.

Article  CAS  PubMed  Google Scholar 

Biering SB. One antibody to treat them all. Science. 2022;375(6583):803.

Article  PubMed  Google Scholar 

Angelo KM, Stoney RJ, Brun-Cottan G, Leder K, Grobusch MP, Hochberg N, Kuhn S, Bottieau E, Schlagenhauf P, Chen L, et al. Zika among international travellers presenting to GeoSentinel sites, 2012–2019: implications for clinical practice. J Travel Med. 2020;27:27(4).

Article  Google Scholar 

Hamer DH, Barbre KA, Chen LH, Grobusch MP, Schlagenhauf P, Goorhuis A, van Genderen PJ, Molina I, Asgeirsson H, Kozarsky PE, et al. Travel-Associated Zika Virus Disease Acquired in the Americas through February 2016: a GeoSentinel Analysis. Ann Intern Med. 2017;166(2):99–108.

Article  PubMed  Google Scholar 

Baud D, Gubler DJ, Schaub B, Lanteri MC, Musso D. An update on Zika virus Infection. Lancet. 2017;390(10107):2099–109.

Article  PubMed  Google Scholar 

Karimi O, Goorhuis A, Schinkel J, Codrington J, Vreden SGS, Vermaat JS, Stijnis C, Grobusch MP. Thrombocytopenia and subcutaneous bleedings in a patient with Zika virus Infection. Lancet. 2016;387(10022):939–40.

Article  PubMed  Google Scholar 

Esquivel RN, Patel A, Kudchodkar SB, Park DH, Stettler K, Beltramello M, Allen JW, Mendoza J, Ramos S, Choi H, et al. In vivo delivery of a DNA-Encoded monoclonal antibody protects non-human Primates against Zika Virus. Mol Ther. 2019;27(5):974–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Aalst M, Nelen CM, Goorhuis A, Stijnis C, Grobusch MP. Long-term sequelae of Chikungunya virus Disease: a systematic review. Travel Med Infect Dis. 2017;15:8–22.

Article  PubMed  Google Scholar 

Broeckel R, Fox JM, Haese N, Kreklywich CN, Sukulpovi-Petty S, Legasse A, Smith PP, Denton M, Corvey C, Krishnan S, et al. Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of Chikungunya virus Disease in rhesus macaques. PLoS Negl Trop Dis. 2017;11(6): e0005637.

Article  PubMed  PubMed Central  Google Scholar 

Miner JJ, Cook LE, Hong JP, Smith AM, Richner JM, Shimak RM, Young AR, Monte K, Poddar S, Crowe JE Jr, et al. Therapy with CTLA4-Ig and an antiviral monoclon